Impact of antimicrobial stewardship programs on antibiotic consumption and antimicrobial resistance in four Colombian healthcare institutions

Background: Antimicrobial stewardship programs (ASPs) have become a fundamental pillar in optimizing antimicro‑ bial usage, improving patient care, and reducing antimicrobial resistance (AMR). Herein we evaluated the impact of an ASP on antimicrobial consumption and AMR in Colombia. Methods: We desi...

Descripción completa

Detalles Bibliográficos
Autores: Pallares, Christian, Hernández-Gómez, Cristhian, Appel, Tobías Manuel, Escandón, Kevin, Reyes, Sergio, Salcedo, Soraya, Rodríguez-Baño, Jesús, Villegas, María Virginia
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:España
Institución:Universidad de Sevilla (US)
Repositorio:idUS. Depósito de Investigación de la Universidad de Sevilla
OAI Identifier:oai:idus.us.es:11441/139460
Acceso en línea:https://hdl.handle.net/11441/139460
https://doi.org/10.1186/s12879-022-07410-6
Access Level:acceso abierto
Palabra clave:Antimicrobial stewardship
Antimicrobial stewardship program
Descripción
Sumario:Background: Antimicrobial stewardship programs (ASPs) have become a fundamental pillar in optimizing antimicro‑ bial usage, improving patient care, and reducing antimicrobial resistance (AMR). Herein we evaluated the impact of an ASP on antimicrobial consumption and AMR in Colombia. Methods: We designed a retrospective observational study and measured trends in antibiotic consumption and AMR before and after the implementation of an ASP using interrupted time series analysis over a 4-year period (24 months before and 24 months after ASP implementation). Results: ASPs were implemented according to the available resources in each of the institutions. Before ASP imple‑ mentation, there was a trend toward an increase in the antibiotic consumption of all measured antimicrobials selected. Afterward, an overall decrease in antibiotic consumption was observed. The use of ertapenem and mero‑ penem decreased in hospital wards, while a decrease in the use of ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, and vancomycin was observed in intensive care units. After ASP implementation, the trend toward an increase of oxacillin-resistant Staphylococcus aureus, ceftriaxone-resistant Escherichia coli, and meropenem-resistant Pseudomonas aeruginosa was reversed. Conclusions: In our study, we showed that ASPs are a key strategy in tackling the emerging threat of AMR and have a positive impact on antibiotic consumption and resistance.